Expanding HTA – Correcting a Misattribution, Clarifying the Scope of HTA and CEA; Comment on “Ethics in HTA: Examining the ‘Need for Expansion’”

Document Type: Commentary

Author

Department of Economics and Related Studies and Centre for Health Economics, University of York, York, UK

Abstract

Abrishami, Oortwijn, and Hofman (AOH) attribute to me a position I do not hold and an argument I did not make. The purpose of this note is make clear what my position actually is and to clarify the main differences between health technology assessment (HTA) and cost-effectiveness analysis (CEA).

Keywords

Main Subjects


  1. Abrishami P, Oortwijn W, Hofmann B. Ethics in HTA: Examining the "Need for Expansion". Int J Health Policy Manag. 2017;6(10):551-553. doi:10.15171/ijhpm.2017.43
  2. Culyer AJ. HTA - Algorithm or Process? Comment on "Expanded HTA: Enhancing Fairness and Legitimacy". Int J Health Policy Manag. 2016;5(8):501-505. doi:10.15171/ijhpm.2016.59
  3. Daniels N, Porteny T, Urritia J. Expanded HTA: Enhancing Fairness and Legitimacy. Int J Health Policy Manag. 2015;5(1):1-3. doi:10.15171/ijhpm.2015.187
  4. Brouwer WB, Culyer AJ, van Exel NJ, Rutten FF. Welfarism vs. extra-welfarism. J Health Econ. 2008;27(2):325-338. doi:10.1016/j.jhealeco.2007.07.003
  5. Culyer AJ. Where are the limits of cost-effectiveness analysis and health technology assessment? J Med Assoc Thai. 2014;97(Suppl 5):S1-S2.
  6. Culyer AJ. NICE's use of cost effectiveness as an exemplar of a deliberative process. Health Econ Policy Law. 2006;1(Pt 3):299-318. doi:10.1017/s1744133106004026
  7. Culyer AJ. Deliberative processes in decisions about health care technologies: combining different types of evidence, values, algorithms and people. London: Office of Health Economics; 2009.
  8. Chalkidou K, Li R, Culyer AJ, Glassman A, Hofman KJ, Teerawattananon Y. Health Technology Assessment: Global Advocacy and Local Realities Comment on "Priority Setting for Universal Health Coverage: We Need Evidence-Informed Deliberative Processes, Not Just More Evidence on Cost-Effectiveness". Int J Health Policy Manag. 2016;6(4):233-236. doi:10.15171/ijhpm.2016.118
  9. Wilkinson T, Sculpher MJ, Claxton K, et al. The International Decision Support Initiative Reference Case for Economic Evaluation: An Aid to Thought. Value Health. 2016;19(8):921-928. doi:10.1016/j.jval.2016.04.015